Urachal Carcinoma with Peritoneal Dissemination Treated with Chemotherapy and Surgical Resection Leading to Prolonged Survival with No Recurrence

Table 1

Previous reports of urachal adenocarcinoma with peritoneal dissemination treated with cytoreductive surgery.

Author	Age	Gender	pre-operative therapy	HIPEC	post-operative therapy	time to recurrence; (months)	Post-recurrence therapy	time to death; (months)
Krane LS et al. [3]	unknown	M	unknown	Mitomycin C	unknown	11	5-FU	21
	unknown	M	unknown	Mitomycin C	unknown	31	carbolpatin, FOLFORI	87
Sugarbaker PH et al. [4]	32	F	none	EPIC	none	24	surgery + HIPEC	132
			none	Mitomycin C	none	NED at 20 months	-	-
Martinez A et al. [5]	32	M	none	oxaliplatin	none	NED at 24 months	-	-
Ozawa M et al. [6]	48	M	none	none	TS-1 + cisplatin	NED at 10 months	-	-
Yasui M et al.	56	M	GC / FOLFIRI	none	none	NED at 62months	-	-

HIPEC, hyperthermic intraperitoneal chemotherapy; EPIC, early postoperative intraperitoneal chemotherapy; GC, gemcitabine + cisplatin, FOLFIRI, ℓ-leucovorin + 5-flourouracil + irinotecan; NED, no evidence of disease
study